AZ0108
AZ0108 : NAD+ competitive inhibitor of PARP1, PARP2, PARP6
Structure
In Cells
In Model Organisms
SERP ratings and comments
SERP Ratings
SERP Comments:
Probe use in model organism: A further publication concerning in-depth details of the biological effects was announced in the key reference paper (reference 23).
(last updated: 12 Aug 2016 )
SERP Ratings
SERP Comments:
AZ0108 potently declusters centrosomes in HeLa cells (EC50 = 53 nM) and kills a DLBCL cell line (GI50 = 17 nM). More studies are needed to determine how useful this probe is, including linking the phenotype and cell death in the same cell line.
(last updated: 8 Sept 2016 )
SERP Ratings
SERP Comments:
AZ0108 is also reported to have a GI50 of 0.017 uM in the DLBCL cell line OCI-LY-19. Although this compound seems promising, additional studies are needed to determine how useful it will be as a probe. I would have like to see some images of cells that no longer had a multi-polar spindle phenotype.
(last updated: 8 Sept 2016 )
SERP Comments:
AZ0108 is a more selective PARP enzyme inhibitor (i.e., PARP 1, 2, and 6) compared with other more broad-acting PARP inhibitors. AZ0108 has cellular effects.
(last updated: 12 Sept 2016 )
Portal Comments
AZ0108 is a more selective PARP enzyme inhibitor (i.e., PARP 1, 2, and 6) compared with other more broad-acting PARP inhibitors. AZ0108 has cellular effects.
(last updated: 12 Sept 2016)